Fulgent Genetics Inc.
Organization details
- Legal name
- Fulgent Genetics Inc.
- Former names
- Fulgent Diagnostics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- EL Monte
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FLGT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001674930
- EIN
- 81-2621304
- Wikidata ID
- Q66823616
Board of directors
-
Linda Marsh · DirectorSince 2023
-
Michael Nohaile · DirectorSince 2023
-
Ming Hsieh · Director · Chief Executive OfficerSince 2023
-
Regina E. Groves · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
73.0%
-
77.6%
-
98.8%
Board connections
3 of this board's directors also sit on 3 other boards. 1 is in the same sector.
- via Linda Marsh
-
AtriCure Inc. Same sectorvia Regina E. Groves
- via Ming Hsieh
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $677,628
- 15 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 26, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −2,748 | $20.22 | $55,565 |
| Oct 26, 2026 | Xie Jian Officer (President and COO) | Shares withheld for tax | −4,361 | $20.22 | $88,179 |
| Oct 26, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Shares withheld for tax | −1,645 | $20.22 | $33,262 |
| Sep 2, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Open-market sale | −1,673 | $19.66 | $32,891 |
| Sep 2, 2026 | Xie Jian Officer (President and COO) | Open-market sale | −2,127 | $19.66 | $41,817 |
| Sep 1, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −2,087 | $19.59 | $40,884 |
| Sep 1, 2026 | Ming Hsieh Director, Officer (Chief Executive Officer), 10% owner | Shares withheld for tax | −4,392 | $19.59 | $86,039 |
| Aug 27, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Open-market sale | −939 | $19.91 | $18,695 |
| Aug 27, 2026 | Xie Jian Officer (President and COO) | Open-market sale | −1,193 | $19.91 | $23,753 |
| Aug 26, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −1,168 | $19.81 | $23,138 |
| Aug 26, 2026 | Ming Hsieh Director, Officer (Chief Executive Officer), 10% owner | Shares withheld for tax | −2,949 | $19.81 | $58,420 |
| Jul 26, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Shares withheld for tax | −1,645 | $19.67 | $32,357 |
| Jul 26, 2026 | Xie Jian Officer (President and COO) | Shares withheld for tax | −4,361 | $19.67 | $85,781 |
| Jul 26, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −2,747 | $19.67 | $54,033 |
| Jun 2, 2026 | Xie Jian Officer (President and COO) | Open-market sale | −2,146 | $17.89 | $38,392 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Fulgent Genetics Inc.
Who is the CEO of Fulgent Genetics Inc.?
Ming Hsieh is Fulgent Genetics Inc.'s Chief Executive Officer.
How many directors are on Fulgent Genetics Inc.'s board?
Fulgent Genetics Inc.'s board has 4 directors: Linda Marsh, Michael Nohaile, Ming Hsieh and Regina E. Groves.
Are Fulgent Genetics Inc. insiders buying or selling shares?
Over the last 12 months, Fulgent Genetics Inc. insiders made no open-market purchases and sold $677,628 of shares in 15 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="fulgent-genetics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.